Funding
Researcher : Aintzane Zabaleta Azpiroz
8 funding - 1,041,370€
2021
-
Evaluation of the therapeutic efficacy of BCMA-targeted cost
euro 173,368.00
2020
-
Understanding the Alterations in the Bone Marrow Microenviro
euro 273,000.00
2019
-
Amyloidosis antibodies project
euro 19,384.00
-
MECHANISM OF ACTION ANTI-CD38 IN MM AND AML
euro 91,200.00
-
Evaluation of the therapeutic efficacy of a compound in MM
euro 120,300.00
-
Evaluation of TriNKET in BMA samples from MM patients
euro 96,600.00
-
Fibroblast Activation Factor (FAP) in Amyloidosis and MM
euro 103,260.00
2018
-
Inmunomonitorización de nueva generación en mieloma múltiple
euro 164,258.00